Sex-specific neurobiological actions of prophylactic (R,S)-ketamine, (2R,6R)-hydroxynorketamine, and (2S,6S)-hydroxynorketamine

被引:45
作者
Chen, Briana K. [1 ]
Luna, Victor M. [2 ,3 ]
LaGamma, Christina T. [2 ,9 ]
Xu, Xiaoming [4 ,5 ]
Deng, Shi-Xian [4 ,5 ]
Suckow, Raymond F. [3 ,6 ]
Cooper, Thomas B. [3 ,6 ]
Shah, Abhishek [7 ]
Brachman, Rebecca A. [3 ]
Mendez-David, Indira [8 ]
David, Denis J. [8 ]
Gardier, Alain M. [8 ]
Landry, Donald W. [4 ,5 ]
Denny, Christine A. [2 ,3 ]
机构
[1] Columbia Univ, Doctoral Program Neurobiol & Behav, New York, NY 10027 USA
[2] Neurosci Res Fdn Mental Hyg Inc, Div Syst Neurosci, RFMH New York State Psychiat Inst NYSPI, New York, NY 10032 USA
[3] Columbia Univ, Dept Psychiat, Irving Med Ctr CUIMC, New York, NY 10032 USA
[4] Columbia Univ, Dept Med, New York, NY 10032 USA
[5] Columbia Univ, Organ Chem Collaborat Ctr OCCC, Dept Med, New York, NY 10032 USA
[6] Nathan S Kline Inst Psychiat Res NKI, Orangeburg, NY 10962 USA
[7] Columbia Univ, Ij Rabi Scholars Program, New York, NY 10027 USA
[8] Univ Paris Saclay, Ctr Rech Epidemiol & Sante Populat, INSERM, Fac Pharm, F-92290 Chatenay Malabry, France
[9] Penn State Coll Med, Hershey, PA 17033 USA
关键词
TREATMENT-RESISTANT DEPRESSION; POSTTRAUMATIC-STRESS-DISORDER; NMDA RECEPTOR BLOCKADE; GENDER-DIFFERENCES; ANTIDEPRESSANT ACTIONS; DOUBLE-BLIND; KETAMINE; NEUROTRANSMISSION; COMORBIDITY; ESKETAMINE;
D O I
10.1038/s41386-020-0714-z
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Enhancing stress resilience in at-risk populations could significantly reduce the incidence of stress-related psychiatric disorders. We have previously reported that the administration of (R,S)-ketamine prevents stress-induced depressive-like behavior in male mice, perhaps by altering alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR)-mediated transmission in hippocampal CA3. However, it is still unknown whether metabolites of (R,S)-ketamine can be prophylactic in both sexes. We administered (R,S)-ketamine or its metabolites (2R,6R)-hydroxynorketamine ((2R,6R)-HNK) and (2S,6S)-hydroxynorketamine ((2S,6S)-HNK) at various doses 1 week before one of a number of stressors in male and female 129S6/SvEv mice. Patch clamp electrophysiology was used to determine the effect of prophylactic drug administration on glutamatergic activity in CA3. To examine the interaction between ovarian hormones and stress resilience, female mice also underwent ovariectomy (OVX) surgery and a hormone replacement protocol prior to drug administration. (2S,6S)-HNK and (2R,6R)-HNK protected against distinct stress-induced behaviors in both sexes, with (2S,6S)-HNK attenuating learned fear in male mice, and (2R,6R)-HNK preventing stress-induced depressive-like behavior in both sexes. (R,S)-ketamine and (2R,6R)-HNK, but not (2S,6S)-HNK, attenuated large-amplitude AMPAR-mediated bursts in hippocampal CA3. All three compounds reduced N-methyl-D-aspartate receptor (NMDAR)-mediated currents 1 week after administration. Furthermore, ovarian-derived hormones were necessary for and sufficient to restore (R,S)-ketamine- and (2R,6R)-HNK-mediated prophylaxis in female mice. Our data provide further evidence that resilience-enhancing prophylactics may alter AMPAR-mediated glutamatergic transmission in CA3. Moreover, we show that prophylactics against stress-induced depressive-like behavior can be developed in a sex-specific manner and demonstrate that ovarian hormones are necessary for the prophylactic efficacy of (R,S)-ketamine and (2R,6R)-HNK in female mice.
引用
收藏
页码:1545 / 1556
页数:12
相关论文
共 50 条
  • [41] A Phase 1 Assessment of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of (2R,6R)-Hydroxynorketamine in Healthy Volunteers
    Raja, Shruti M.
    Guptill, Jeffrey T.
    Mack, Michelle
    Peterson, Marni
    Byard, Stephen
    Twieg, Robert
    Jordan, Lynn
    Rich, Natalie
    Castledine, Richard
    Bourne, Samuel
    Wilmshurst, Martin
    Oxendine, Sarah
    Avula, Satya G. C.
    Zuleta, Helen
    Quigley, Paul
    Lawson, Sheila
    McQuaker, Stephen J.
    Ahmadkhaniha, Reza
    Appelbaum, Lawrence G.
    Kowalski, Kevin
    Barksdale, Chineta T.
    Gufford, Brandon T.
    Awan, Asaad
    Sancho, Alfredo R.
    Moore, Max C.
    Berrada, Karim
    Cogan, Gregory B.
    DeLarosa, Jesse
    Radcliffe, Jeanne
    Pao, Maryland
    Kennedy, Michelle
    Lawrence, Quentin
    Goldfeder, Lisa
    Amanfo, Leslie
    Zanos, Panos
    Gilbert, Jessica R.
    Morris, Patrick J.
    Moaddel, Ruin
    Gould, Todd D.
    Zarate, Carlos A.
    Thomas, Craig J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 116 (05) : 1314 - 1324
  • [42] (2R,6R)-hydroxynorketamine rapidly potentiates optically-evoked Schaffer collateral synaptic activity
    Riggs, Lace M.
    Thompson, Scott M.
    Gould, Todd D.
    NEUROPHARMACOLOGY, 2022, 214
  • [43] Stereochemical and structural effects of (2R,6R)-hydroxynorketamine on the mitochondrial metabolome in PC-12 cells
    Faccio, Andrea T.
    Ruperez, Francisco J.
    Singh, Nagendra S.
    Angulo, Santiago
    Tavares, Marina F. M.
    Bernier, Michel
    Barbas, Coral
    Wainer, Irving W.
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2018, 1862 (06): : 1505 - 1515
  • [44] (2R,6R)-Hydroxynorketamine Alleviates Electroconvulsive Shock-Induced Learning Impairment by Inhibiting Autophagy
    Zhong, Xiaomei
    Ouyang, Cong
    Liang, Wanyuan
    Dai, Cunying
    Zhang, Weiru
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2021, 17 : 297 - 304
  • [45] Simple Enantioselective Syntheses of (2R,6R)-Hydroxynorketamine and Related Potential Rapid-Onset Antidepressants
    Han, Yixin
    Reddy, Karla Mahender
    Corey, E. J.
    ORGANIC LETTERS, 2017, 19 (19) : 5224 - 5227
  • [46] (2 R,6 R)-Hydroxynorketamine Exerts mGluR2-Dependent Antidepressant Actions
    Zanos, Panos
    Highland, Jaclyn
    Georgiou, Polymnia
    Stewart, Brent
    Bonaventura, Jordi
    Lam, Sherry
    Zarate, Carlos, Jr.
    Michaelides, Michael
    Gould, Todd
    NEUROPSYCHOPHARMACOLOGY, 2018, 43 : S243 - S243
  • [47] Sexually Dimorphic Behavioral Profile in a Transgenic Model Enabling Targeted Recombination in Active Neurons in Response to Ketamine and (2R,6R)-Hydroxynorketamine Administration
    Herzog, David P.
    Mellema, Ratnadevi M.
    Remmers, Floortje
    Lutz, Beat
    Mueller, Marianne B.
    Treccani, Giulia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (06)
  • [48] (2R,6R)-hydroxynorketamine prevents opioid abstinence-related negative affect and stress-induced reinstatement in mice
    Michael, Andria
    Onisiforou, Anna
    Georgiou, Polymnia
    Koumas, Morfeas
    Powels, Chris
    Mammadov, Elmar
    Georgiou, Andrea N.
    Zanos, Panos
    BRITISH JOURNAL OF PHARMACOLOGY, 2025,
  • [49] Effects of (2R,6R)-hydroxynorketamine in assays of acute pain-stimulated and pain-depressed behaviors in mice
    Hillhouse, Todd M.
    Partridge, Kaitlyn J.
    Garrett, Patrick I.
    Honeycutt, Sarah C.
    Porter, Joseph H.
    PLOS ONE, 2024, 19 (04):
  • [50] cAMP-dependent protein kinase signaling is required for (2R,6R)-hydroxynorketamine to potentiate hippocampal glutamatergic transmission
    Riggs, Lace M.
    Pereira, Edna F. R.
    Thompson, Scott M.
    Gould, Todd D.
    JOURNAL OF NEUROPHYSIOLOGY, 2024, 131 (01) : 64 - 74